It has been also described that the CCL5/CCR5 axis increased cellular invasiveness via the induction of MMPs [44,45,46], and, more specifically, CCL5 modulated glioma cells’ migratory and invasive activities due to MMP2 upregulation [47]. The gene discussed is CCR5; the disease is central nervous system cancer.